91. バッド・キアリ症候群 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 3 / 薬物数 : 4 - (DrugBank : 3) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 12
薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
Dabigatran
Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology
2012 - JPRN-UMIN000015319 Japan
Rivaroxaban
The First Affiliated Hospital of Zhengzhou University
2022 - ChiCTR2100046725 China
Rivaroxaban 20 MG
University of Insubria
2020 Phase 4 EUCTR2014-005162-29-NL Canada;France;Germany;Italy;Netherlands
Warfarin
The First Affiliated Hospital of Zhengzhou University
2022 - ChiCTR2100046725 China
Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology
2012 - JPRN-UMIN000015319 Japan
Rivaroxaban
The First Affiliated Hospital of Zhengzhou University
2022 - ChiCTR2100046725 China
Rivaroxaban 20 MG
University of Insubria
2020 Phase 4 EUCTR2014-005162-29-NL Canada;France;Germany;Italy;Netherlands
Warfarin
The First Affiliated Hospital of Zhengzhou University
2022 - ChiCTR2100046725 China